文献速递衰弱、肌少症与跌倒老年综合评估老年慢病共病管理

衰弱或衰弱前期老年择期手术患者的多模式监督预康复:多中心随机对照结局评估者盲法试验

Supervised multimodal prehabilitation of older patients with frailty or prefrailty before elective surgery: a multicentre randomised controlled outcome assessor-blinded trial.
PubMed 文献 · Lancet Healthy Longev · 2026-09-15

PRAEP-GO 试验在德国 19 家医院纳入 70 岁及以上衰弱或衰弱前期择期手术患者,比较 3 周多模式个体化监督预康复与标准照护。主要结局为术后 12 个月长期照护依赖(LCD)变化,两组无显著差异(p=0·33),绝对组间差异 -0·1(95%CI -0·25 至 0·07;p=0·26)。

要点

  • 3 周监督多模式预康复未降低术后 12 个月照护依赖。
  • LCD 变化组间绝对差异 -0·1(95%CI -0·25 至 0·07;p=0·26)。
  • 不宜将短程监督预康复作为该类患者普遍术前路径。

核心结论

  • 3 周监督多模式个体化预康复未减少衰弱或衰弱前期老年患者术后 12 个月照护依赖。
  • 短程监督预康复不应作为该类患者普遍术前路径实施。

研究设计与样本

  • 多中心、平行组、随机对照试验,结局评估者盲法,在德国 19 家医院开展。
  • 纳入 70 岁及以上、按 Fried 身体衰弱表型定义衰弱或衰弱前期、拟行择期手术者。
  • 随机分配 1382 例,改良意向性分析纳入 1199 例(预康复组 616 例、标准照护组 583 例)。

主要发现

  • 基线中位年龄 78 岁(IQR 74-82),女性 653 例(54%),骨科手术 617 例(51%)。
  • 30 次监督训练中完成中位数 29·5 次(IQR 26-30)。
  • LCD 变化组间绝对差异 -0·1(95%CI -0·25 至 0·07;p=0·26),有序 LCD 变化 p=0·33。
  • 预康复组发生 32 起安全性事件,多与干预无关或仅可能相关。

关键数值与推荐

  • 干预为 3 周个体化预康复,含 30 次监督 30 分钟课程及 18 次额外非监督课程建议。
  • 课程可涵盖运动治疗、营养治疗、认知或心理支持及拐杖训练、用药审查、社会服务支持等。
  • 主要结局 LCD 采用 0(无依赖)至 5(最高依赖)有序量表评估。

临床怎么用

  • 不应将 3 周监督多模式预康复作为衰弱或衰弱前期老年择期手术患者的普遍术前路径。
  • 未来项目与报销政策应优先考虑更长程、基于行为改变的干预及提高参与度的策略。
  • 应识别最可能获益的亚组人群。

局限性

  • 因德国数据保护法和伦理批准,未收集种族和族裔数据。
  • 研究 personnel 除结局评估者外未设盲。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Frailty is an increasing perioperative risk in our ageing society, and prehabilitation can mitigate this vulnerability. This trial aimed to investigate if a multimodal, individualised prehabilitation programme could maintain independence and avoid further deterioration of long-term care dependency (LCD) in patients undergoing elective surgery. METHODS: Prehabilitation of elderly frail or pre-frail patients prior to elective surgery (PRAEP-GO) was a multicentre, parallel-group, randomised controlled trial with blinded outcome assessment comparing a 3-week multimodal, individualised prehabilitation programme designed with shared decision making with standard of care in participants aged 70 years or older with frailty or prefrailty (defined using Fried's physical frailty phenotype) who were scheduled for elective surgery across 19 hospitals in Germany. Participants were randomly assigned by a web-based random 1:1 group allocation procedure. Study personnel were not blinded, except for outcome assessors. In the intervention group shared decision making was used to define patient goals. This was followed by a 3-week personalised prehabilitation programme consisting of 30 supervised 30-min sessions and a recommendation for 18 additional unsupervised sessions during this period focused on these goals. Sessions could cover exercise therapy, nutritional therapy, cognitive or psychological support, and other supportive components such as crutch training, medication review, or social service support. The primary outcome was the change in LCD from baseline to 12 months after surgery. LCD was assessed on an ordinal scale from 0 (no dependency) to 5 (highest dependency), analysed primarily as modified intention-to-treat (defined as all randomly assigned patients, except those who withdrew consent immediately after randomisation and those for whom no treatment was initiated and no post-randomisation follow-up data were available). FINDINGS: Between June 27, 2020, and July 14, 2023, 3193 patients were assessed for eligibility, with a screening halt from Oct 30, 2020, to March 1, 2021, owing to the COVID-19 pandemic. The last patient was randomly assigned on July 13, 2023, and the final follow-up was completed on Aug 1, 2024. Of the 1382 randomly assigned participants, 1199 had baseline and 12-month LCD (616 in the prehabilitation group and 583 the standard care group) and were included in the modified intention-to-treat analysis. Baseline characteristics were balanced (median age 78 [IQR 74-82] years; 653 (54%) women; 617 (51%) underwent orthopaedic procedures). In accordance with German data-protection law and the trial ethics approval, race and ethnicity data were not collected. A median of 29·5 (IQR 26-30) of 30 sessions were completed. Change in ordinal LCD from baseline to month 12 did not differ significantly between groups (p=0·33), with an absolute between-group difference in change over time of -0·1 (95% CI -0·25 to 0·07; p=0·26). 32 safety events occurred in the prehabilitation group, mostly unrelated or only possibly related to the intervention. The trial was registered at ClinicalTrials.gov (NCT04418271). INTERPRETATION: A 3-week supervised, multimodal, individualised prehabilitation programme, designed with shared decision making for older patients with frailty or prefrailty undergoing elective surgery did not reduce care dependency 12 months after surgery in this trial. These findings indicate that supervised, short-duration prehabilitation should not be implemented as a universal preoperative pathway for these patients. Future programmes and reimbursement policies should prioritise longer, behaviour change-based interventions; strategies to improve uptake and engagement; and the identification of subgroups most likely to benefit. FUNDING: Innovation Fund (Innovationsfond) of the German Federal Joint Committee (G-BA) by Grant 01NVF18024.

来源:Lancet Healthy Longev,查看原文。版权归原作者所有。

引用

  1. Spies C, Schmidt K, Kiselev J, et al. Supervised multimodal prehabilitation of older patients with frailty or prefrailty before elective surgery: a multicentre randomised controlled outcome assessor-blinded trial. Lancet Healthy Longev. 2026. PMID: 42743945. doi:10.1016/j.lanhl.2026.100899

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。